KEY
43
-3
NOV
52
-5
GILD
47
-8
GIS
22
-4
AIV
64
4
TXT
53
-3
HAS
30
-2
TSCO
44
-4
UAL
83
-2
DLTR
38
-4
SO
57
6
OXY
36
-2
DNB
74
-6
EXR
57
2
FFIV
66
-4
MLM
45
-5
ICE
59
-3
TSN
50
-2
F
56
-3
CB
57
2
KEY
43
-3
NOV
52
-5
GILD
47
-8
GIS
22
-4
AIV
64
4
TXT
53
-3
HAS
30
-2
TSCO
44
-4
UAL
83
-2
DLTR
38
-4
SO
57
6
OXY
36
-2
DNB
74
-6
EXR
57
2
FFIV
66
-4
MLM
45
-5
ICE
59
-3
TSN
50
-2
F
56
-3
CB
57
2
Financhill
Back

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Vs. Avidity Biosciences Industry Stock Comparison

Sell
32

GCV
GABELLI CONVERTIBLE & INCOME SECURITIES FUND

Last Price:
3.79
Seasonality Move:
2.55%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
32
GABELLI CONVERTIBLE & INCOME SECURITIES FUND (GCV) is a Sell

Is GABELLI CONVERTIBLE & INCOME SECURITIES FUND a Buy, Sell or Hold?

  • The current GABELLI CONVERTIBLE & INCOME SECURITIES FUND [GCV] share price is $3.81. The Score for GCV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GCV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GCV Stock Price Chart

What is GABELLI CONVERTIBLE & INCOME SECURITIES FUND's stock price today?

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

GCV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.62 Buy
Chaikin Money Flow: 80 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.69 - 3.81) Buy
Bollinger Bands (100): (3.64 - 3.9) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

GCV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.84 Sell
20-day SMA: 3.76 Buy
50-day SMA: 3.79 Buy
200-day SMA: 3.7 Buy
8-day EMA: 3.82 Sell
20-day EMA: 3.78 Buy
50-day EMA: 3.77 Buy
200-day EMA: 3.76 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Earnings Growth & GCV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.24 per share.

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):